UNRESECTABLE ACRAL MELANOMA
Clinical trials for UNRESECTABLE ACRAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE ACRAL MELANOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE ACRAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made vaccine targets tough cancers in early trial
⭐️ VACCINE ⭐️ Recruiting nowThis early-phase study is testing a personalized vaccine made from each patient's unique tumor mutations. The goal is to see if it is safe and can help the immune system fight advanced breast cancer, melanoma, and non-small cell lung cancer. About 25 adults whose cancers have spr…
Matched conditions: UNRESECTABLE ACRAL MELANOMA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:52 UTC
-
Morning may matter: new trial tests timing of melanoma treatment
Symptom relief Recruiting nowThis study tests whether giving immunotherapy drugs (ipilimumab and nivolumab) in the morning works better than other times of day for people with advanced melanoma that has spread or cannot be removed. About 99 adults with stage IV or unresectable melanoma will be randomly assig…
Matched conditions: UNRESECTABLE ACRAL MELANOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 17, 2026 13:45 UTC